

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jul 24, 2026 accepted 10:37 PM ET | NEUPNeuphoria Therapeutics Inc. | 1.01Material agreement5.01Change in control7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 8, 2026 accepted 10:48 PM ET | NEUPNeuphoria Therapeutics Inc. |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
1.01Material agreement1.02Agreement terminated |
| DocumentSEC ↗ |
Dec 18, 2025 accepted 9:15 PM ET | NEUPNeuphoria Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 16, 2025 accepted 1:03 PM ET | NEUPNeuphoria Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jul 18, 2025 accepted 9:00 PM ET | NEUPNeuphoria Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Dec 23, 2024 accepted 10:14 PM ET | NEUPNeuphoria Therapeutics Inc. | 1.01Material agreement3.01Delisting notice3.02Unregistered equity sale3.03Holder rights modified5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year5.05Code of ethics8.01Other events | DocumentSEC ↗ |
Jul 16, 2024 accepted 10:30 AM ET | NEUPNeuphoria Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |